Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived From Centrocytes in the Germinal Center
Xin Li(China Medical University), Ken H. Young(Duke Medical Center), Nancy L. Harris(World Resources Institute), Jason R. Westin(The University of Texas MD Anderson Cancer Center), Shuhua Yi(Chinese Academy of Medical Sciences & Peking Union Medical College), Zijun Y. Xu‐Monette(Duke University), Nathan Fowler(Repligen (United States)), Roberto N. Miranda(The University of Texas MD Anderson Cancer Center), Ganiraju C. Manyam(The University of Texas MD Anderson Cancer Center), Mingzhi Zhang(Chinese Academy of Sciences), L. Jeffrey Medeiros(Delaware Division of Libraries), Bouthaina S. Dabaja(The University of Texas MD Anderson Cancer Center), Judith A. Ferry(Harvard University)
Cited by 41
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k